Literature DB >> 1833118

Urinary transferrin excretion in type 1 (insulin-dependent) diabetes mellitus.

M J O'Donnell1, P Martin, C M Florkowski, M J Toop, C Chapman, R Holder, A H Barnett.   

Abstract

Urinary excretion of transferrin and albumin was studied by radioimmunoassay in 47 adult patients with Type 1 diabetes and 28 control subjects. Median (range) urinary transferrin excretion rate was significantly elevated in the diabetic group 0.58 (0.02-2663.3) micrograms min-1 compared with the control group 0.04 (0.01-0.28) micrograms min-1, p less than 0.001. Urinary transferrin:creatinine ratios (x 10(2)) were different in diabetic 47 (0.6-958.0) micrograms mmol-1 and control groups 0.7 (0.06-2.3) micrograms mmol-1, p less than 0.001). There were correlations between urinary transferrin and albumin excretion rates in diabetic (r = 0.78, p less than 0.001) and control groups (r = 0.81, p less than 0.05). Forty (85%) diabetic patients had elevated transferrin excretion rates, 18 (38.3%) had elevated albumin excretion rates. All diabetic patients with elevated albumin excretion rates had elevated transferrin excretion rates. Twenty-one (77.8%) of the patients with normal albumin excretion rates had elevated transferrin excretion rates. Urinary excretion of N-acetyl-beta-D-glucosaminidase was greater in diabetic patients than control subjects (142 vs 58 mumol h-1 l-1, p less than 0.001). There were correlation between transferrin and N-acetyl-beta-D-glucosaminidase excretion (r = 0.67, p less than 0.01) and albumin and N-acetyl-beta-D-glucosaminidase excretion (r = 0.63, p less than 0.01) in the diabetic group. Elevated urinary transferrin excretion rate may be a marker for renal dysfunction in diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833118     DOI: 10.1111/j.1464-5491.1991.tb01673.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  5 in total

1.  Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset.

Authors:  Thomas O Metz; Wei-Jun Qian; Jon M Jacobs; Marina A Gritsenko; Ronald J Moore; Ashoka D Polpitiya; Matthew E Monroe; David G Camp; Patricia W Mueller; Richard D Smith
Journal:  J Proteome Res       Date:  2007-12-20       Impact factor: 4.466

2.  Non enzymatic glycosylation of IgG and their urinary excretion in patients with diabetic nephropathy.

Authors:  Kinnari Mistry; Kiran Kalia
Journal:  Indian J Clin Biochem       Date:  2009-07-09

3.  Urinary markers of glomerular injury in diabetic nephropathy.

Authors:  Abraham Cohen-Bucay; Gautham Viswanathan
Journal:  Int J Nephrol       Date:  2012-05-08

Review 4.  Acute phase reactants as novel predictors of cardiovascular disease.

Authors:  M S Ahmed; A B Jadhav; A Hassan; Qing H Meng
Journal:  ISRN Inflamm       Date:  2012-05-06

Review 5.  The role of novel biomarkers in predicting diabetic nephropathy: a review.

Authors:  Samuel N Uwaezuoke
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-08-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.